Skip to main content
. Author manuscript; available in PMC: 2021 Aug 19.
Published in final edited form as: Urol Oncol. 2020 Dec 9;39(7):432.e1–432.e10. doi: 10.1016/j.urolonc.2020.11.024

Fig. 4.

Fig. 4.

Trends in initial treatment of new localized prostate cancer by race and Gleason score, SEER-Medicare, 2004–2015. Percent of patients undergoing prostatectomy, IMRT, other active treatment, active surveillance, or no treatment by treatment year, race (non-Hispanic white, non-Hispanic black), and Gleason score (6 and below, 7 and above). IMRT = intensity-modulated radiation therapy, SEER = Surveillance, Epidemiology, and End Results.